Trial Profile
A Prospective, Open-label, Non-randomized, Naturalistic, Long-term Safety Surveillance, Observational Study of Either Ciprofloxacin (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) or a Non-quinolone Antibiotic (Either as Oral Suspension, Oral Tablets or Sequential IV Followed by Oral Therapy or Purely IV Therapy) in the Treatment of Pediatric Patients With Infectious Diagnoses
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Aug 2015
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary) ; Ciprofloxacin (Primary) ; Antibacterials
- Indications Bacterial infections; Paediatric infections
- Focus Adverse reactions
- Acronyms QUIP
- Sponsors Bayer
- 18 Apr 2009 Actual patient number (1029) added as reported by ClinicalTrials.gov.
- 18 Apr 2009 Actual initiation date changed from Apr 2000 to Oct 1999 as reported by ClinicalTrials.gov.
- 16 Oct 2008 New trial record.